Iradimed (IRMD) Enterprise Value Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.01% |
| Dec 31, 2025 | 2.06% |
| Sep 30, 2025 | -9.29% |
| Jun 30, 2025 | -9.19% |
| Mar 31, 2025 | -11.53% |
| Dec 31, 2024 | -4.97% |
| Sep 30, 2024 | -10.64% |
| Jun 30, 2024 | -5.92% |
| Mar 31, 2024 | -5.49% |
| Dec 31, 2023 | 14.15% |
| Sep 30, 2023 | 15.91% |
| Jun 30, 2023 | 12.15% |
| Mar 31, 2023 | 16.04% |
| Dec 31, 2022 | 7.26% |
| Sep 30, 2022 | 6.28% |
| Jun 30, 2022 | 7.04% |
| Mar 31, 2022 | 3.34% |
| Dec 31, 2021 | -20.25% |
| Sep 30, 2021 | -18.94% |
| Jun 30, 2021 | -17.42% |
| Mar 31, 2021 | -11.15% |
| Dec 31, 2020 | -12.38% |
| Sep 30, 2020 | -17.16% |
| Jun 30, 2020 | -26.40% |
| Mar 31, 2020 | -33.83% |
| Dec 31, 2019 | -34.54% |
| Sep 30, 2019 | -36.48% |
| Jun 30, 2019 | -28.14% |
| Mar 31, 2019 | -26.90% |
| Dec 31, 2018 | -30.51% |
| Sep 30, 2018 | -23.70% |
| Jun 30, 2018 | -23.83% |
| Mar 31, 2018 | -10.60% |
| Dec 31, 2017 | -2.58% |
| Sep 30, 2017 | -5.86% |
| Jun 30, 2017 | -18.25% |
| Mar 31, 2017 | -7.18% |
| Dec 31, 2016 | 4.79% |
| Sep 30, 2016 | -1.69% |
| Jun 30, 2016 | 0.92% |
| Mar 31, 2016 | -25.94% |
| Dec 31, 2015 | -55.29% |
| Sep 30, 2015 | -29.29% |
| Jun 30, 2015 | -350.34% |
| Mar 31, 2015 | -543.00% |
| Dec 31, 2014 | -541.41% |
| Sep 30, 2014 | -786.64% |
| Jun 30, 2014 | -108.80% |